Mary Faris

1.1k total citations
18 papers, 962 citations indexed

About

Mary Faris is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mary Faris has authored 18 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Mary Faris's work include Immune Cell Function and Interaction (4 papers), Cell death mechanisms and regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mary Faris is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Cell death mechanisms and regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mary Faris collaborates with scholars based in United States and Italy. Mary Faris's co-authors include André E. Nel, Niels Kokot, Gary A. Koretzky, Kevin Latinis, Stephan J. Kempiak, Shu Man Fu, Shailaja Kasibhatla, Douglas R. Green, J. Thomas Parsons and Felicia Gaskin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Mary Faris

18 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Faris United States 13 521 338 199 188 67 18 962
Jean‐Louis Vigne United States 22 550 1.1× 536 1.6× 127 0.6× 158 0.8× 17 0.3× 36 1.5k
Dennis Sakai United States 11 425 0.8× 171 0.5× 77 0.4× 132 0.7× 47 0.7× 17 887
Nancy Davis United States 11 276 0.5× 247 0.7× 277 1.4× 58 0.3× 55 0.8× 14 625
Dat X. Nghiem United States 15 212 0.4× 586 1.7× 74 0.4× 120 0.6× 60 0.9× 19 1.1k
M.F. El Etreby Germany 24 366 0.7× 96 0.3× 103 0.5× 174 0.9× 33 0.5× 75 1.3k
Franca Saccucci Italy 16 450 0.9× 174 0.5× 165 0.8× 182 1.0× 18 0.3× 39 955
Michela Galdieri Italy 20 579 1.1× 114 0.3× 73 0.4× 85 0.5× 37 0.6× 60 1.5k
Panayiotis E. Stevis United States 14 457 0.9× 117 0.3× 120 0.6× 87 0.5× 21 0.3× 25 1.1k
Emilia Middea Italy 15 458 0.9× 93 0.3× 140 0.7× 78 0.4× 49 0.7× 15 1.3k
Li-Xin Shan United States 11 386 0.7× 169 0.5× 66 0.3× 159 0.8× 44 0.7× 17 1.1k

Countries citing papers authored by Mary Faris

Since Specialization
Citations

This map shows the geographic impact of Mary Faris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Faris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Faris more than expected).

Fields of papers citing papers by Mary Faris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Faris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Faris. The network helps show where Mary Faris may publish in the future.

Co-authorship network of co-authors of Mary Faris

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Faris. A scholar is included among the top collaborators of Mary Faris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Faris. Mary Faris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tolaney, Sara M., et al.. (2025). The Mode of Action and Clinical Outcomes of Sacituzumab Govitecan in Solid Tumors. Clinical Cancer Research. 31(8). 1390–1399. 5 indexed citations
2.
Faris, Mary. (2008). Potential for Molecular Targeted Therapy for Adult T-Cell Leukemia/Lymphoma. International Reviews of Immunology. 27(1-2). 71–78. 7 indexed citations
3.
Abreu-Martin, Maria T., et al.. (1999). Fas activates the JNK pathway in human colonic epithelial cells: lack of a direct role in apoptosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 276(3). G599–G605. 38 indexed citations
4.
Faris, Mary, Kevin Latinis, Stephan J. Kempiak, Gary A. Koretzky, & André E. Nel. (1998). Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter. Molecular and Cellular Biology. 18(9). 5414–5424. 176 indexed citations
5.
Faris, Mary, Niels Kokot, Kevin Latinis, et al.. (1998). The c-Jun N-Terminal Kinase Cascade Plays a Role in Stress-Induced Apoptosis in Jurkat Cells by Up-Regulating Fas Ligand Expression. The Journal of Immunology. 160(1). 134–144. 218 indexed citations
6.
Shau, Hungyi, Andrew C. Huang, Mary Faris, et al.. (1998). Thioredoxin Peroxidase (Natural Killer Enhancing Factor) Regulation of Activator Protein-1 Function in Endothelial Cells. Biochemical and Biophysical Research Communications. 249(3). 683–686. 35 indexed citations
9.
Faris, Mary, Niels Kokot, Neil Stahl, & André E. Nel. (1997). Involvement of Stat3 in interleukin‐6‐induced IgM production in a human B‐cell line. Immunology. 90(3). 350–357. 18 indexed citations
11.
Faris, Mary, Niels Kokot, Leo Lee, & André E. Nel. (1996). Regulation of Interleukin-2 Transcription by Inducible Stable Expression of Dominant Negative and Dominant Active Mitogen-activated Protein Kinase Kinase Kinase in Jurkat T Cells. Journal of Biological Chemistry. 271(44). 27366–27373. 67 indexed citations
13.
Faris, Mary, et al.. (1994). The induction of persistence of I-A expression by macrophages from Bcgr mice occurs via a protein kinase C-dependent pathway.. The Journal of Immunology. 152(3). 1323–1331. 12 indexed citations
14.
Faris, Mary, et al.. (1993). Tyrosine phosphorylation defines a unique transduction pathway in human B cells mediated via CD40.. PubMed. 106. 187–95. 5 indexed citations
15.
Faris, Mary & Bruce S. Zwilling. (1991). Characterization of the Induction of Persistent I-A Expression by Macrophages From Bcgr Mice. Journal of Leukocyte Biology. 49(3). 289–293. 3 indexed citations
16.
Faris, Mary & Bruce S. Zwilling. (1990). Somatic cell hybrids between macrophages from Bcgr and Bcgs mice: Characterization of MHC class II expression. Cellular Immunology. 127(1). 120–129. 1 indexed citations
17.
Dinkins, Michael B., et al.. (1990). Restraint stress-induced suppression of major histocompatibility complex class II expression by murine peritoneal macrophages. Journal of Neuroimmunology. 29(1-3). 125–130. 41 indexed citations
18.
Zwilling, Bruce S., et al.. (1990). Differential effect of restraint stress on MHC class II expression by murine peritoneal macrophages. Brain Behavior and Immunity. 4(4). 330–338. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026